|
|
|
|
Vol. 19, Issue 11, 4738-4749, November 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||


*INSERM EMI 229, Genotypes et phenotypes tumoraux, Centre de Recherche en Cancerologie de Montpellier, CRLC Val d'Aurelle-Paul Lamarque, 34298 Montpellier, France;
Institut de Génétique Moléculaire de Montpellier, UMR 5535 CNRS, 34293 Montpellier, France; and
INSERM U456, 35043 Rennes, France
Submitted October 26, 2007;
Revised August 8, 2008;
Accepted August 12, 2008
Monitoring Editor: M. Bishr Omary
Reepithelialization during cutaneous wound healing involves numerous signals that result in basal keratinocyte activation, spreading, and migration, all linked to a loosening of cell–cell adhesion structures. The transcription factor Slug is required for this process, and EGF treatment of human keratinocytes induced activating phosphorylation of Erk5 that coincides with slug transcription. Accordingly, ectopic activation of Erk5 led to increased Slug mRNA levels and faster wound healing, whereas keratinocyte migration was totally blocked by Erk5 pathway inhibition. Expression of a shRNA specific for Erk5 strongly diminished Erk5 levels in keratinocytes and significantly decreased their motility response to EGF, along with induction of Slug expression. These Erk5-deprived keratinocytes showed an altered, more compact morphology, along with disruption of desmosome organization. Accordingly, they displayed an altered ability to form cell aggregates. These results implicate a novel EGFR/Erk5/Slug pathway in the control of cytoskeleton organization and cell motility in keratinocytes treated with EGF.
Address correspondence to: Pierre Savagner (psavagner{at}valdorel.fnclcc.fr)